Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway

Osteoarthritis and Cartilage

Volumn 10, Issue 10, 2002, Pages 792-798

  Fermor, B ^a   Weinberg, J B ^b   Pisetsky, D S ^b   Misukonis, M A ^b   Fink, C ^a   Guilak, F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Articular cartilage; Chondrocyte; Inflammatory mediators; Osteoarthrits; Prostaglandin; Rheumatoid arthritis; Signal transduction

Indexed keywords

AUTACOID; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BIOMECHANICS; COMPRESSION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SELECTIVITY; DRUG TARGETING; ENZYME INDUCTION; ENZYME REGULATION; ENZYME SYNTHESIS; EXPLANT; FEMALE; HOMEOSTASIS; IMMUNOBLOTTING; INHIBITION KINETICS; MECHANICAL STRESS; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SWINE;

EID: 0036793145     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2002.0832     Document Type: Article

References (47)

1. Guilak F, Sah R, Setton LA. Physical regulation of cartilage metabolism. In: Mow VC, Hayes WC, Eds. Basic Orthopaedics Biomechanics. Philadelphia: Lippincott-Raven 1997:179-208.
2. Howell DS, Treadwell BV, Trippel SB. Etiopathogenesis of osteoarthritis. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, Eds. Osteoarthritis, Diagnosis and Medical/Surgical Management. 2nd ed. Philadelphia: W.B. Saunders 1992:233-52.
3. Minor MA. Exercise in the treatment of osteoarthritis. Osteoarthritis 1999;25:397-415.
4. Clancy RM, Varenika B, Huang W, Ballou L, Attur M, Amin A, et al. Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 2000; 165:1582-7.
5. O'Banion M. Cyclooxygenase-2: Molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 1999;13(1): 45-82.
6. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Int J Tissue React 1998;20(1): 3-15.
7. Harris E. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322: 1277.
8. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1beta, phorbol ester, and corticosteroids. J Clin Inv 1994;93:1095-101.
9. Abramson SB. The role of COX-2 produced by cartilage in arthritis. Osteoarthritis Cart 1999;7(4): 380-1.
10. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91(6): 2046-50.
11. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin-6 in rat adjuvant arthritis. J Clin Inv 1996;97:2672-9.
12. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benze nesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40(9): 1347-65.
13. Stefanovic-Racic N, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-Monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant induced arthritis in rats. Arthritis Rheum 1994;7:1062-9.
14. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179:651-60.
15. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41(7): 1141-51.
16. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH. Nitric oxide in osteoarthritis. Osteoarthritis Cart 1999;7(4): 377-9.
17. Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Banes AB, Guilak F. The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res 2001;19: 72-80.
18. Fink C, Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Guilak F. The effect of dynamic mechanical compression on nitric oxide production in the meniscus. Osteoarthritis Cart 2001;9:481-7.
19. Manfield L, Jang D, Murrell GA. Nitric oxide enhances cyclooxygenase activity in articular cartilage. Inflamm Res 1996;45(5): 254-8.
20. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 1997;99(6): 1231-7.
21. Weinberg JB. Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation. Immunologic Research 2001;22:319-41.
22. Rawlinson SCF, Mosley JR, Suswillo RFL, Pitsillides AA, Lanyon LE. Calvarial and limb bone cells in organ and monolayer culture do not show the same early responses to dynamic mechanical strain. J Bone Miner Res 1995;10:1225-32.
23. Fermor B, Gundle R, Evans M, Emerton M, Pocock A, Murray D. Primary human osteoblast proliferation and PGE2 release in response to mechanical strain in vitro. Bone 1998;22:637-43.
24. Osanai T, Fujita N, Fujiwara N, Nakano T, Takahashi K, Guan W, et al. Cross talk of shear-induced production of prostacyclin and nitric oxide in endothelial cells. Am J Physiol 2000;278(1): H233-8.
25. Weinberg JB, Misukonis MA, Shami PJ, Mason SM, Sauls DM, Dittman WA, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS). Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995;86:1184-95.
26. Sah RL, Kim YJ, Doong JY, Grodzinsky AJ, Plaas AH, Sandy JD. Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res 1989;7(5):619-36.
27. Guilak F, Meyer BC, Ratcliffe A, Mow VC. The effects of matrix compression on proteoglycan metabolism in articular cartilage explants. Osteoarthritis Cart 1994;2:91-101.
28. Dingle J. Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair. J Rheumatol Suppl 1991;28:30.
29. Lowe GN, Fu YH, McDougall S, Polendo R, Williams A, Benya PD, et al. Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 1996;137(6): 2208-16.
30. Di Battista JA, Dore S, Martel-Pelletier J, Pelletier JP. Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I. Mol Cell Endocrinol 1996;123(1): 27-35.
31. Stockwell RA. Structure and function of the chondrocyte under mechanical stress. In: Helminen HJ, Kiviranta I, Tammi M, Eds. Joint Loading: Biology and Health of Articular Structures. Bristol: Wright and Sons 1987:126-48.
32. Guilak F, Zell RA, Erickson GR, Grande DA, Rubin CT, McLeod KJ, et al. Mechanically induced calcium waves in articular chondrocytes are inhibited by gadolinium and amiloride. J Orthop Res 1999;17(3): 421-9.
33. Gijon MA, Leslie CC. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol 1999;65:330-6.
34. Blanco FJ, Lotz M. IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 1995;218(1): 319-25.
35. Di Battista JA, Martel-Pelletier J, Fujimoto N, Obata K, Zafarullah M, Pelletier JP. Prostaglandins E2 and E1 inhibit cytokine-incluced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway. Lab Invest 1994;71(2): 270-8.
36. Milano S, Arcoleo F, Dieli M, D'Agostino R, D'Agostino P, De Nucci G, et al. Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 1995;49(2): 105-15.
37. Xu Z, Buckley M, Evans C, Agarwal S. Cyclic tensile strain acts as an antagonist of IL1beta actions in chondrocytes. J Immunol 2000;165:453-60.
38. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 2000;403(6765): 103-8.
39. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391(6662): 79-82.
40. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82-6.
41. Mbalaviele G, Abu-Amer Y, Meng A, Jaiswal R, Beck S, Pittenger MF, et al. Activation of peroxisome proliferator-activated receptor-gamma pathway inhibits osteoclast differentiation. J Biol Chem 2000;275:14388-93.
42. Henrotin YE, Zheng SX, Deby GP, Labasse AH, Crielaard JMR, Reginster JYL. Nitric oxide downregulates interleukin 1-beta (IL-1-beta) stimulated IL-6, IL-8, and prostaglandin E-2 production by human chondrocytes. J Rheumatol 1998;25(8): 1595-601.
43. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41(7): 1275-86.
44. Patel R, Attur MG, Dave M, Abramson SB, Amin AR. Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J Immunol 1999;162(7): 4191-7.
45. McCartney-Francis NL, Song X, Mizel DE, Wahl SM. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol 2001; 166:2734-40.
46. Paul-Clark MJ, Gilroy DW, Willis D, Willoughby DA, Tomlinson A. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. J Immunol 2001;166: 1169-77.
47. Jarvinen TA, Moilanen T, Jarvinen TL, Moilanen E. Endogenous nitric oxide and prostaglandin E2 do not regulate the synthesis of each other in interleukin-1 beta-stimulated rat articular cartilage. Inflammation 1996;20(6): 683-92.